SCHEMBL1785136

SCHEMBL1785136

CCC1CNC(C)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30900010 1.00
SCHEMBL23055125 1.00
Hydrochloric Acid SCHEMBL4187172 0.97 GBA1 (0.31)
SCHEMBL8069758 0.86 GANAB (0.36)
SCHEMBL294003 0.86 GANAB (0.36)
SCHEMBL19974975 0.86 GANAB (0.36)
SCHEMBL23058736 0.86 GANAB (0.36)
SCHEMBL8069756 0.86 GANAB (0.36)
SCHEMBL31348000 0.86 GANAB (0.36)
SCHEMBL31348002 0.86 GANAB (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4628199-A1 COMPOSITE SEMIPERMEABLE MEMBRANE, COMPOSITE SEMIPERMEABLE MEMBRANE ELEMENT, AND FILTER DEVICE Toray Industries, Inc. (JP) 2025-10-08 EP disclosed
US-20240300951-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-09-12 US disclosed
US-20240270751-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-08-15 US disclosed
WO-2024117238-A1 COMPOSITE SEMIPERMEABLE MEMBRANE, COMPOSITE SEMIPERMEABLE MEMBRANE ELEMENT, AND FILTER DEVICE 東レ株式会社 2024-06-06 WO disclosed
US-11866428-B2 Bicyclic heterocycle compounds and their uses in therapy ASTEX THERAPEUTICS LIMITED (GB) 2024-01-09 US disclosed
CN-116509988-A Male reproduction auxiliary preparation and preparation method thereof 安徽安科余良卿药业有限公司 2023-08-01 CN disclosed
CN-114302884-A Substituted pyridopyrimidinone based compounds useful as T cell activators 百时美施贵宝公司 2022-04-08 CN disclosed
US-10316022-B2 Urea derivatives and uses thereof KALA PHARMACEUTICALS, INC. (US) 2019-06-11 US disclosed
WO-2019030197-A1 PROCESS TO PREPARE PROPYLENE AMINES AND PROPYLENE AMINE DERIVATIVES AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2019-02-14 WO disclosed
EP-2986604-B1 PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2017-12-20 EP disclosed
EP-0880990-A1 Process for removing carbon dioxide from gases THE KANSAI ELECTRIC POWER CO., INC. (JP) 1998-12-02 EP disclosed
EP-0880991-A1 Process for removing carbon dioxide from gases THE KANSAI ELECTRIC POWER CO., INC. (JP) 1998-12-02 EP disclosed
EP-0879631-A1 Process for removing carbon dioxide from gases THE KANSAI ELECTRIC POWER CO., INC. (JP) 1998-11-25 EP disclosed
US-5618506-A USING AN HYDROXYALKYLAMINE THE KANSAI ELECTRIC POWER CO., INC. (JP) 1997-04-08 US disclosed
EP-0705637-A1 Process for removing carbon dioxide from gases THE KANSAI ELECTRIC POWER CO., INC. (JP) 1996-04-10 EP disclosed
US-4560755-A VASODILATOR, HYPOTENSOR ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-12-24 US disclosed
US-4525589-A Isoquinolinesulfonyl derivatives ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-06-25 US disclosed
EP-0061673-B1 ISOQUINOLINESULFONYL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-10-24 EP disclosed
US-4456757-A MUSCLE RELAXANTS, VASODILATORS, HYPOTENSIVE AGENTS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1984-06-26 US disclosed
EP-0061673-A1 Isoquinolinesulfonyl derivatives and process for the preparation thereof Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-10-06 EP disclosed